The expression of DLL3 on the tumor tissues of patients with invasive breast cancer can promote the infiltration of immune cells, including plasma cells, CD8 T cells, CD44 memory-activated cells, macrophages, and T regulatory cells [70]. The gene discussed is CD8A; the disease is neoplasm.